Heart disease due to atherosclerosis, also known as hardening of the arteries, is a critical problem for children with progeria. Most die of heart disease by  age  13. According to the National Osteoporosis Foundation, most girls develop about 90% of their bone mass by age 18 and boys by age 20. This is why children with progeria have such issues with bone density and rigidity. However, encouraging results from the first clinical drug trial for children with progeria has researchers hopeful that the first treatment for the disease could be on the horizon.